Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Oxygen Enrichment Protocols – V 2.0

Posted on By


Biosimilars: SOP for Oxygen Enrichment Protocols – V 2.0


Standard Operating Procedure for Oxygen Enrichment Protocols in Biosimilar Bioreactor Operations

Department Biosimilars
SOP No. SOP/BS/105/2025
Supersedes SOP/BS/105/2022
Page No. Page 1 of 11
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the protocol for controlled oxygen enrichment in bioreactor systems used for biosimilar production to maintain optimal dissolved oxygen (DO) levels required for healthy cell growth and viability.

2. Scope

This SOP applies to all pilot and production scale bioreactors in the upstream biosimilar manufacturing facility that utilize automated or manual oxygen enrichment systems.

3. Responsibilities

  • Bioreactor Operator: Execute oxygen enrichment based on DO setpoints, monitor DO probes, and log enrichment events.
  • Supervisor: Approve oxygen enrichment activation and ensure all parameters are within defined ranges.
  • Engineering: Maintain oxygen supply lines and validate gas flow sensors.

4. Accountability

The Head of Manufacturing is accountable for ensuring safe and validated oxygen enrichment operations during upstream runs.

5. Procedure

5.1 Pre-Operation Checks

  1. Ensure oxygen cylinders or centralized liquid oxygen tank is functional and connected securely.
  2. Check for calibration of DO sensors and flowmeters before batch start.
  3. Verify interlock between DO controller and mass flow controller (MFC) for oxygen line.

5.2 DO Control Setpoints

  1. Set desired DO setpoint (e.g., 40% ± 5%) in the SCADA interface.
  2. Allow default cascade control:
    • Air sparging (primary)
    • Agitation ramp-up
    • Oxygen enrichment (final tier)

5.3 Oxygen Enrichment Activation

  1. If DO drops below threshold (<35%), oxygen enrichment is auto-triggered or may be manually started.
  2. Manually enrich by opening the MFC or valve controlling oxygen line to maintain setpoint.
  3. Do not exceed oxygen flow rate of 0.1 vvm unless approved by supervisor.

5.4 Monitoring During Enrichment

  1. Continuously monitor:
    • DO trend graph
    • Cell viability
    • Foam generation
  2. Log enrichment time, duration, oxygen flow rate in Annexure-1.

5.5 Safety and Alarms

  1. Ensure all enrichment lines are fitted with non-return valves to avoid backflow.
  2. Monitor for high DO alarms (>70%) and reduce oxygen immediately if triggered.
  3. Report any leak or pressure anomalies to Engineering immediately.

5.6 Post-Operation

  1. Close oxygen valves and purge lines after batch completion.
  2. Clean oxygen sparger and verify MFC is within calibration (Annexure-2).

6. Abbreviations

  • DO: Dissolved Oxygen
  • MFC: Mass Flow Controller
  • vvm: Volume of gas per volume of liquid per minute
  • QA: Quality Assurance

7. Documents

  1. Oxygen Enrichment Log – Annexure-1
  2. Oxygen Line and MFC Check Record – Annexure-2

8. References

  • ICH Q8 – Pharmaceutical Development
  • FDA Guidance for Industry: Process Validation (2011)

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Oxygen Enrichment Log

Date Batch No. DO % Before O₂ Flow Rate (vvm) Start Time End Time Logged By
04/05/2025 BS-214 32% 0.05 10:20 11:00 Sunita Reddy

Annexure-2: Oxygen Line and MFC Check Record

Date Equipment ID Checked By Calibration Due Status
04/05/2025 MFC-203 Ajay Verma 31/07/2025 OK

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Included MFC safety checks and DO alarm thresholds Process improvement
See also  Biosimilars: SOP for In-Process Sample Collection During Purification - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Creams: SOP for Conducting Inline Microbial Testing of Cream Products – V 2.0
Next Post: Aerosol: SOP for Preventive Maintenance of HVAC Systems in Manufacturing Areas – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version